UPDATE: Imperial Capital Initiates Diebold Incorporated with Outperform, $47 PT on Strategy, Opportunities

Loading...
Loading...
Imperial Capital initiates its coverage on Diebold Incorporated
DBD
with a rating of Outperform and a $47 price target. Imperial Capital comments, "We believe DBD is strongly positioned to capitalize on the financial industry's shift toward self-service transactions. We see particular growth opportunities for DBD's deposit automation solutions, with a total addressable market of over 90,000 ATMs in North America and representing a multi-year upgrade cycle globally." DBD closed at $37.55 on Wednesday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetInitiationIntraday UpdateAnalyst Ratingsimperial capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...